tryptophan has been researched along with Chronic Progressive Multiple Sclerosis in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bansi, J; Bloch, W; Dalgas, U; Joisten, N; Kesselring, J; Koliamitra, C; Kool, J; Langdon, D; Schenk, A; Watson, M; Zimmer, P | 1 |
Åkerfeldt, T; Burman, J; Herman, S; Kultima, K; Spjuth, O | 1 |
Bansi, J; Bloch, W; Caminada, D; Dalgas, U; Gonzenbach, R; Joisten, N; Kool, J; Langdon, D; Oberste, M; Purde, MT; Rademacher, A; Schenk, A; Zimmer, P | 1 |
2 trial(s) available for tryptophan and Chronic Progressive Multiple Sclerosis
Article | Year |
---|---|
Persons with secondary progressive and relapsing remitting multiple sclerosis reveal different responses of tryptophan metabolism to acute endurance exercise and training.
Topics: Adult; Endurance Training; Exercise Therapy; Female; Humans; Kynurenine; Male; Middle Aged; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting; Tryptophan | 2018 |
Influence of different rehabilitative aerobic exercise programs on (anti-) inflammatory immune signalling, cognitive and functional capacity in persons with MS - study protocol of a randomized controlled trial.
Topics: Activities of Daily Living; Adult; Biomarkers; Cognition; Cytokines; Exercise Therapy; Exercise Tolerance; Fatigue; High-Intensity Interval Training; Humans; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting; Quality of Life; Single-Blind Method; T-Lymphocytes, Regulatory; Th17 Cells; Time Factors; Treatment Outcome; Tryptophan | 2019 |
1 other study(ies) available for tryptophan and Chronic Progressive Multiple Sclerosis
Article | Year |
---|---|
Biochemical Differences in Cerebrospinal Fluid between Secondary Progressive and Relapsing⁻Remitting Multiple Sclerosis.
Topics: Adult; Case-Control Studies; Female; Humans; Kynurenine; Male; Metabolome; Middle Aged; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting; Phenylalanine; Pyrimidines; Serotonin; Tryptophan | 2019 |